Triall TRL Price 0.00512048

What is Triall?
The project uses technology to make clinical trial processes resistant to tampering and to enable secure connections between isolated systems and parties involved in clinical research.
The first product of Triall was Verial eTMF, a document management application that enables clinical researchers to generate verifiable proof of the existence, integrity, and authenticity of essential clinical trial documents.
Triall will release several applications that are designed to support clinical trial professionals in their day-to-day operations. Existing third-party clinical trial software providers will be able to connect to Triall's blockchain infrastructure thanks to the project.

The goal of the project is to speed up the introduction of safe and affordable new vaccines and therapies into society.

Who are the people who started TRL?

Over the past 3 years, Triall has built an international network of partners and a global advisory board consisting of industry experts and Key Opinion Leaders that support the project.

What makes Triall unique?
The project aims to turn current competitors into cooperators by enabling secure and compliant integrations between currently isolated clinical trial software. The project uses emerging open standards such as Decentralized Identifiers and Verifiable Credentials.